As we know, regulators and manufacturers of ‘vaccines’ have been shielded from liability for death or injury from these experimental drugs unless they were aware of the damage that might foreseeably be caused by them, which would constitute wilful misconduct. Proving this is the challenge.
Three first-of-a-kind cases in Switzerland, the US and Germany are attempting to do precisely that, and if successful, could trigger a cascade of similar cases.
The Swiss case is a criminal complaint against the country’s
regulator of medicines, Swissmedic, filed in July 2022 by Philipp Kruse,
co-president of the Swiss Bar Association, on behalf of a group of plaintiffs.
The complaint alleges that Swissmedic repeatedly violated its due diligence obligations under therapeutic product law because...<<<Read More>>>...
